A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

PHASE2CompletedINTERVENTIONAL
Enrollment

385

Participants

Timeline

Start Date

August 31, 2007

Study Completion Date

March 31, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

AZD9056

DRUG

Etanercept

DRUG

Placebo

Trial Locations (51)

Unknown

Research Site, Aventura

Research Site, Orlando

Research Site, Sarasota

Research Site, Tampa

Research Site, Petoskey

Research Site, Syracuse

Research Site, Portland

Research Site, Olympia

Research Site, Rosario

Research Site, Buenos Aires

Research Site, Córdoba

Research Site, Planta Baja San Juan

Research Site, San Miguel de Tucumán

Research Site, Woolloongabba

Research Site, Woodsville

Research Site, Victoria Park

Research Site, George Town

Research Site, Hasselt

Research Site, Winnipeg

Research Site, St. John's

Research Site, Prague

Research Site, Uherské Hradiště

Research Site, Zlín

Research Site, Bobigny

Research Site, Bordeaux

Research Site, Tours

Research Site, Cd. Juarez

Research Site, Chihuahua City

Research Site, Guadalajara

Research Site, Mexico City

Research Site, Tapachula

Research Site, Tijuana

Research Site, Bialystok

Research Site, Elblag

Research Site, Katowice

Research Site, Krakow

Research Site, Lublin

Research Site, Poznan

Research Site, Sopot

Research Site, Torun

Research Site, Warsaw

Research Site, Brasov

Research Site, Bucharest

Research Site, Cluj-Napoca

Research Site, Iași

Research Site, Ploieşti

Research Site, Sf. Gheorghe

Research Site, Saint Petersburg

Research Site, Bansky Bystrica

Research Site, Bratislava

Research Site, Piešťany

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00520572 - A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA) | Biotech Hunter | Biotech Hunter